Chester County News and Community Website
WILMINGTON, DE — AstraZeneca and Daiichi Sankyo reported that their drug ENHERTU® (fam-trastuzumab deruxtecan-nxki) achieved highly statistically significant and clinically meaningful improvements in invasive disease-free survival (IDFS) compared to trastuzumab …
ENHERTU Shows Strong Results in Early Breast Cancer Trial Read More
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has announced new funding to support quality improvement projects aimed at advancing breast cancer outcomes. The …
NCCN Oncology Research Program Announces New Funding for Breast Cancer Quality Initiatives Read More
AUDUBON, PA — CertaPro Painters® has launched its seventh annual Paint it Pink campaign in partnership with the Breast Cancer Research Foundation (BCRF) and Breast Cancer Canada, continuing its mission …
CertaPro Painters Launches Seventh Annual ‘Paint It Pink’ Campaign for Breast Cancer Research Read More WILMINGTON, DE — AstraZeneca and Daiichi Sankyo announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to their supplemental Biologics License Application (sBLA) for …
FDA Grants Priority Review for ENHERTU Combo in Advanced Breast Cancer Read More
BENSALEM, PA — Parx Casino® has announced a $10,000 donation to Penn Medicine’s Basser Center for BRCA as part of its expanded commitment to Breast Cancer Awareness Month. The contribution, …
Parx Casino Donates $15,000 to Advance Breast Cancer Awareness and Support Read More
WILMINGTON, DE — NiKang Therapeutics Inc. announced it has completed dosing in the first patient cohort of its Phase 1 dose-escalation study evaluating NKT5097, an oral small molecule designed to …
NiKang Therapeutics Advances First-in-Class CDK2/4 Dual Degrader in Phase 1 Study Read More
CHICAGO, IL & EXTON, PA — SimBioSys® and Ricoh 3D for Healthcare, LLC, a subsidiary of Ricoh USA, have entered into a distribution agreement to expand access to TumorSight™ Viz, …
SimBioSys and Ricoh Partner to Expand Access to 3D Breast Cancer Surgical Planning Tool Read More
WILMINGTON, DE — A groundbreaking study by ChristianaCare’s Cawley Center for Translational Cancer Research has identified key factors behind Delaware’s elevated rates of advanced breast cancer and laid the groundwork for …
New ChristianaCare Study Pinpoints Causes Behind Delaware’s Breast Cancer Hotspots Read More WILMINGTON, DE — The Phase III DESTINY-Breast09 clinical trial has delivered groundbreaking results, demonstrating that ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab significantly improves progression-free survival (PFS) for patients with HER2-positive metastatic …
ENHERTU plus Pertuzumab Shows Significant Progress in First-Line Treatment for HER2-Positive Breast Cancer Read More WILMINGTON, DE — Groundbreaking results from AstraZeneca’s Phase III SERENA-6 trial reveal a significant leap forward in the treatment of hormone receptor (HR)-positive, HER2-negative advanced breast cancer. The trial demonstrated …
AstraZeneca’s SERENA-6 Trial Marks Breakthrough in Breast Cancer Treatment Read More